• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无心跳供体热缺血时间与死后循环死亡肝移植后再灌注综合征的发展有关。

Asystolic donor warm ischemia time is associated with development of postreperfusion syndrome in donation after circulatory death liver transplant.

机构信息

Recanati-Miller Transplantation Institute, the Icahn School of Medicine at Mount Sinai, New York City, New York, USA.

Department of Anesthesiology, Perioperative and Pain Medicine, the Icahn School of Medicine at Mount Sinai, New York City, New York, USA.

出版信息

Clin Transplant. 2024 May;38(5):e15336. doi: 10.1111/ctr.15336.

DOI:10.1111/ctr.15336
PMID:38762783
Abstract

BACKGROUND

Individual events during donation after circulatory death (DCD) procurement, such as hypotensive or hypoxic warm ischemia, or circulatory arrest are all a part of donor warm ischemia time (dWIT), and may have differing effects on the outcome of the liver graft. This study aimed to identify risk factors for postreperfusion syndrome (PRS), a state of severe hemodynamic derangement following graft reperfusion, and its impact on DCD liver transplantation (LT) outcomes.

METHODS

This was a retrospective analysis using 106 DCD LT. Detailed information for events during procurement (withdrawal of life support; systolic blood pressure < 80 mmHg; oxygen saturation < 80%; circulatory arrest; aortic cold perfusion) and their association with the development of PRS were examined using logistic regression.

RESULTS

The overall incidence of PRS was 26.4%, occurring in 28 patients. Independent risk factors for PRS were asystolic dWIT (odds ratio (OR) 3.65, 95% confidence interval (CI) 1.38-9.66) and MELD score (OR 1.06, 95% CI 1.01-1.10). Total bilirubin was significantly higher in the PRS group at postoperative day (POD) 1 (p = .02; 5.2 mg/dL vs. 3.4 mg/dL), POD 3 (p = .049; 4.5 mg/dL vs. 2.8 mg/dL), and POD 7 (p = .04; 3.1 mg/dL vs. 1.9 mg/dL). Renal replacement therapy after LT was more likely to be required in the PRS group (p = .01; 48.2% vs. 23.1%).

CONCLUSION

Asystolic dWIT is a risk factor for the development of PRS in DCD LT. Our results suggest that asystolic dWIT should be considered when selecting DCD liver donors.

摘要

背景

在心跳停止死亡后供体器官获取过程中的个体事件,如低血压或低氧性热缺血,或循环停止,都是供体热缺血时间(dWIT)的一部分,并且可能对肝移植物的结果产生不同的影响。本研究旨在确定再灌注后综合征(PRS)的危险因素,PRS 是移植物再灌注后严重血流动力学紊乱的状态,及其对 DCD 肝移植(LT)结果的影响。

方法

本研究使用 106 例 DCD-LT 进行回顾性分析。使用逻辑回归检查获取过程中事件(停止生命支持;收缩压<80mmHg;氧饱和度<80%;循环停止;主动脉冷灌注)的详细信息及其与 PRS 发展的相关性。

结果

PRS 的总发生率为 26.4%,发生在 28 例患者中。PRS 的独立危险因素是停搏性 dWIT(比值比(OR)3.65,95%置信区间(CI)1.38-9.66)和 MELD 评分(OR 1.06,95%CI 1.01-1.10)。PRS 组在术后第 1 天(p=0.02;5.2mg/dL 比 3.4mg/dL)、第 3 天(p=0.049;4.5mg/dL 比 2.8mg/dL)和第 7 天(p=0.04;3.1mg/dL 比 1.9mg/dL)的总胆红素明显更高。PRS 组在 LT 后更有可能需要肾脏替代治疗(p=0.01;48.2%比 23.1%)。

结论

停搏性 dWIT 是 DCD-LT 中 PRS 发展的危险因素。我们的结果表明,在选择 DCD 肝供体时应考虑停搏性 dWIT。

相似文献

1
Asystolic donor warm ischemia time is associated with development of postreperfusion syndrome in donation after circulatory death liver transplant.无心跳供体热缺血时间与死后循环死亡肝移植后再灌注综合征的发展有关。
Clin Transplant. 2024 May;38(5):e15336. doi: 10.1111/ctr.15336.
2
Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.常温及低温机器灌注保存与静态冷藏在尸体供肾移植中的比较。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD011671. doi: 10.1002/14651858.CD011671.pub3.
3
Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: a systematic review.体外膜肺氧合在循环死亡供者腹部器官区域性灌注中的应用:系统评价。
Liver Transpl. 2013 Dec;19(12):1292-303. doi: 10.1002/lt.23771.
4
Mitochondrial injury during normothermic regional perfusion (NRP) and hypothermic oxygenated perfusion (HOPE) in a rodent model of DCD liver transplantation.在 DCD 肝移植的啮齿动物模型中,常温区域性灌注(NRP)和低温氧合灌注(HOPE)过程中的线粒体损伤。
EBioMedicine. 2023 Dec;98:104861. doi: 10.1016/j.ebiom.2023.104861. Epub 2023 Nov 3.
5
Treating Donation After Circulatory Death Liver Grafts With Alteplase During Ex Situ Normothermic Machine Perfusion.在体外常温机器灌注期间用阿替普酶治疗心脏死亡后捐献的肝脏移植物
Clin Transplant. 2025 Aug;39(8):e70282. doi: 10.1111/ctr.70282.
6
Comparisons of liver transplant from DCD outcomes in high-utilization centers versus low-utilization centers in the US: a systematic review and meta-analysis.美国高利用率中心与低利用率中心DCD肝移植结局的比较:一项系统评价和荟萃分析。
Front Immunol. 2025 May 9;16:1564551. doi: 10.3389/fimmu.2025.1564551. eCollection 2025.
7
The duration of asystolic ischemia determines the risk of graft failure after circulatory-dead donor kidney transplantation: A Eurotransplant cohort study.心脏停搏时间决定死后供肾移植后移植物失功的风险:一项 Eurotransplant 队列研究。
Am J Transplant. 2018 Apr;18(4):881-889. doi: 10.1111/ajt.14526. Epub 2017 Nov 10.
8
Association of perfusate cytokine concentrations during liver graft ex situ normothermic perfusion to donor type and postoperative outcomes.肝移植供肝体外常温灌注期间灌注液细胞因子浓度与供体类型及术后结局的相关性
Liver Transpl. 2025 Jul 1;31(7):877-889. doi: 10.1097/LVT.0000000000000583. Epub 2025 Feb 11.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
The effect of warm ischemic intervals on primary graft dysfunction in normothermic regional perfusion for donation after circulatory death heart transplant.
J Thorac Cardiovasc Surg. 2025 Oct;170(4):1109-1116.e3. doi: 10.1016/j.jtcvs.2025.03.037. Epub 2025 May 4.

引用本文的文献

1
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ.调节性细胞死亡和损伤相关分子模式作为移植器官常温灌注中的生物标志物和治疗靶点。第1部分:它们从供体器官损伤中出现的情况。
Front Transplant. 2025 Apr 24;4:1571516. doi: 10.3389/frtra.2025.1571516. eCollection 2025.
2
A Review of the Risk Factors and Approaches to Prevention of Post-Reperfusion Syndrome During Liver Transplantation.肝移植术后再灌注综合征的危险因素及防治策略研究进展
Organogenesis. 2024 Dec 31;20(1):2386730. doi: 10.1080/15476278.2024.2386730. Epub 2024 Aug 4.